0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Asthma Preventive Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-34J7209
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Asthma Preventive Market Insights Forecast to 2028
BUY CHAPTERS

Global Asthma Preventive Market Research Report 2024

Code: QYRE-Auto-34J7209
Report
February 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Asthma Preventive Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Asthma Preventive Market

Asthma Preventive Market

Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
The global Asthma Preventive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Preventive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Preventive.

Report Scope

The Asthma Preventive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Preventive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Preventive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Asthma Preventive Market Report

Report Metric Details
Report Name Asthma Preventive Market
CAGR 5%
Segment by Type
  • Sodium Cromolyn
  • Prednisolone
Segment by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Abbot, Novartis, Roche, GSK, Merck, Astrazeneca, Biotest AG, Boehringer Ingelheim, Chiesi, Sumitomo Dainippon Pharma, Amgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Asthma Preventive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Asthma Preventive Market report?

Ans: The main players in the Asthma Preventive Market are Pfizer, Abbot, Novartis, Roche, GSK, Merck, Astrazeneca, Biotest AG, Boehringer Ingelheim, Chiesi, Sumitomo Dainippon Pharma, Amgen

What are the Application segmentation covered in the Asthma Preventive Market report?

Ans: The Applications covered in the Asthma Preventive Market report are Children, Adult

What are the Type segmentation covered in the Asthma Preventive Market report?

Ans: The Types covered in the Asthma Preventive Market report are Sodium Cromolyn, Prednisolone

1 Asthma Preventive Market Overview
1.1 Product Overview and Scope of Asthma Preventive
1.2 Asthma Preventive Segment by Type
1.2.1 Global Asthma Preventive Market Value Comparison by Type (2024-2030)
1.2.2 Sodium Cromolyn
1.2.3 Prednisolone
1.3 Asthma Preventive Segment by Application
1.3.1 Global Asthma Preventive Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Asthma Preventive Market Size Estimates and Forecasts
1.4.1 Global Asthma Preventive Revenue 2019-2030
1.4.2 Global Asthma Preventive Sales 2019-2030
1.4.3 Global Asthma Preventive Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Preventive Market Competition by Manufacturers
2.1 Global Asthma Preventive Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Preventive Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Preventive Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Preventive Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Preventive, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Preventive, Product Type & Application
2.7 Asthma Preventive Market Competitive Situation and Trends
2.7.1 Asthma Preventive Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Preventive Players Market Share by Revenue
2.7.3 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Preventive Retrospective Market Scenario by Region
3.1 Global Asthma Preventive Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Preventive Global Asthma Preventive Sales by Region: 2019-2030
3.2.1 Global Asthma Preventive Sales by Region: 2019-2024
3.2.2 Global Asthma Preventive Sales by Region: 2025-2030
3.3 Global Asthma Preventive Global Asthma Preventive Revenue by Region: 2019-2030
3.3.1 Global Asthma Preventive Revenue by Region: 2019-2024
3.3.2 Global Asthma Preventive Revenue by Region: 2025-2030
3.4 North America Asthma Preventive Market Facts & Figures by Country
3.4.1 North America Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Preventive Sales by Country (2019-2030)
3.4.3 North America Asthma Preventive Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Preventive Market Facts & Figures by Country
3.5.1 Europe Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Preventive Sales by Country (2019-2030)
3.5.3 Europe Asthma Preventive Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Preventive Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Preventive Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Preventive Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Preventive Market Facts & Figures by Country
3.7.1 Latin America Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Preventive Sales by Country (2019-2030)
3.7.3 Latin America Asthma Preventive Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Preventive Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Preventive Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Preventive Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Preventive Sales by Type (2019-2030)
4.1.1 Global Asthma Preventive Sales by Type (2019-2024)
4.1.2 Global Asthma Preventive Sales by Type (2025-2030)
4.1.3 Global Asthma Preventive Sales Market Share by Type (2019-2030)
4.2 Global Asthma Preventive Revenue by Type (2019-2030)
4.2.1 Global Asthma Preventive Revenue by Type (2019-2024)
4.2.2 Global Asthma Preventive Revenue by Type (2025-2030)
4.2.3 Global Asthma Preventive Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Preventive Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Preventive Sales by Application (2019-2030)
5.1.1 Global Asthma Preventive Sales by Application (2019-2024)
5.1.2 Global Asthma Preventive Sales by Application (2025-2030)
5.1.3 Global Asthma Preventive Sales Market Share by Application (2019-2030)
5.2 Global Asthma Preventive Revenue by Application (2019-2030)
5.2.1 Global Asthma Preventive Revenue by Application (2019-2024)
5.2.2 Global Asthma Preventive Revenue by Application (2025-2030)
5.2.3 Global Asthma Preventive Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Preventive Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Asthma Preventive Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Abbot
6.2.1 Abbot Corporation Information
6.2.2 Abbot Description and Business Overview
6.2.3 Abbot Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbot Asthma Preventive Product Portfolio
6.2.5 Abbot Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Asthma Preventive Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Asthma Preventive Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GSK Asthma Preventive Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Asthma Preventive Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Astrazeneca
6.6.1 Astrazeneca Corporation Information
6.6.2 Astrazeneca Description and Business Overview
6.6.3 Astrazeneca Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astrazeneca Asthma Preventive Product Portfolio
6.7.5 Astrazeneca Recent Developments/Updates
6.8 Biotest AG
6.8.1 Biotest AG Corporation Information
6.8.2 Biotest AG Description and Business Overview
6.8.3 Biotest AG Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biotest AG Asthma Preventive Product Portfolio
6.8.5 Biotest AG Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Asthma Preventive Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Chiesi
6.10.1 Chiesi Corporation Information
6.10.2 Chiesi Description and Business Overview
6.10.3 Chiesi Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chiesi Asthma Preventive Product Portfolio
6.10.5 Chiesi Recent Developments/Updates
6.11 Sumitomo Dainippon Pharma
6.11.1 Sumitomo Dainippon Pharma Corporation Information
6.11.2 Sumitomo Dainippon Pharma Asthma Preventive Description and Business Overview
6.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio
6.11.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.12 Amgen
6.12.1 Amgen Corporation Information
6.12.2 Amgen Asthma Preventive Description and Business Overview
6.12.3 Amgen Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Amgen Asthma Preventive Product Portfolio
6.12.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Preventive Industry Chain Analysis
7.2 Asthma Preventive Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Preventive Production Mode & Process
7.4 Asthma Preventive Sales and Marketing
7.4.1 Asthma Preventive Sales Channels
7.4.2 Asthma Preventive Distributors
7.5 Asthma Preventive Customers
8 Asthma Preventive Market Dynamics
8.1 Asthma Preventive Industry Trends
8.2 Asthma Preventive Market Drivers
8.3 Asthma Preventive Market Challenges
8.4 Asthma Preventive Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Asthma Preventive Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Asthma Preventive Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Asthma Preventive Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Asthma Preventive Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Asthma Preventive Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Asthma Preventive Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Asthma Preventive Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Asthma Preventive Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Asthma Preventive, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Asthma Preventive, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Asthma Preventive, Product Type & Application
    Table 12. Global Key Manufacturers of Asthma Preventive, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Asthma Preventive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Preventive as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Asthma Preventive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Asthma Preventive Sales by Region (2019-2024) & (K Units)
    Table 18. Global Asthma Preventive Sales Market Share by Region (2019-2024)
    Table 19. Global Asthma Preventive Sales by Region (2025-2030) & (K Units)
    Table 20. Global Asthma Preventive Sales Market Share by Region (2025-2030)
    Table 21. Global Asthma Preventive Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Asthma Preventive Revenue Market Share by Region (2019-2024)
    Table 23. Global Asthma Preventive Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Asthma Preventive Revenue Market Share by Region (2025-2030)
    Table 25. North America Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 27. North America Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 28. North America Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Asthma Preventive Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Asthma Preventive Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Asthma Preventive Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Asthma Preventive Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Asthma Preventive Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Asthma Preventive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Asthma Preventive Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Asthma Preventive Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Asthma Preventive Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Asthma Preventive Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Asthma Preventive Sales (K Units) by Type (2019-2024)
    Table 51. Global Asthma Preventive Sales (K Units) by Type (2025-2030)
    Table 52. Global Asthma Preventive Sales Market Share by Type (2019-2024)
    Table 53. Global Asthma Preventive Sales Market Share by Type (2025-2030)
    Table 54. Global Asthma Preventive Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Asthma Preventive Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Asthma Preventive Revenue Market Share by Type (2019-2024)
    Table 57. Global Asthma Preventive Revenue Market Share by Type (2025-2030)
    Table 58. Global Asthma Preventive Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Asthma Preventive Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Asthma Preventive Sales (K Units) by Application (2019-2024)
    Table 61. Global Asthma Preventive Sales (K Units) by Application (2025-2030)
    Table 62. Global Asthma Preventive Sales Market Share by Application (2019-2024)
    Table 63. Global Asthma Preventive Sales Market Share by Application (2025-2030)
    Table 64. Global Asthma Preventive Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Asthma Preventive Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Asthma Preventive Revenue Market Share by Application (2019-2024)
    Table 67. Global Asthma Preventive Revenue Market Share by Application (2025-2030)
    Table 68. Global Asthma Preventive Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Asthma Preventive Price (USD/Unit) by Application (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Asthma Preventive Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Abbot Corporation Information
    Table 76. Abbot Description and Business Overview
    Table 77. Abbot Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Abbot Asthma Preventive Product
    Table 79. Abbot Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis Asthma Preventive Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. Roche Corporation Information
    Table 86. Roche Description and Business Overview
    Table 87. Roche Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Roche Asthma Preventive Product
    Table 89. Roche Recent Developments/Updates
    Table 90. GSK Corporation Information
    Table 91. GSK Description and Business Overview
    Table 92. GSK Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. GSK Asthma Preventive Product
    Table 94. GSK Recent Developments/Updates
    Table 95. Merck Corporation Information
    Table 96. Merck Description and Business Overview
    Table 97. Merck Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Merck Asthma Preventive Product
    Table 99. Merck Recent Developments/Updates
    Table 100. Astrazeneca Corporation Information
    Table 101. Astrazeneca Description and Business Overview
    Table 102. Astrazeneca Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Astrazeneca Asthma Preventive Product
    Table 104. Astrazeneca Recent Developments/Updates
    Table 105. Biotest AG Corporation Information
    Table 106. Biotest AG Description and Business Overview
    Table 107. Biotest AG Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Biotest AG Asthma Preventive Product
    Table 109. Biotest AG Recent Developments/Updates
    Table 110. Boehringer Ingelheim Corporation Information
    Table 111. Boehringer Ingelheim Description and Business Overview
    Table 112. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Boehringer Ingelheim Asthma Preventive Product
    Table 114. Boehringer Ingelheim Recent Developments/Updates
    Table 115. Chiesi Corporation Information
    Table 116. Chiesi Description and Business Overview
    Table 117. Chiesi Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Chiesi Asthma Preventive Product
    Table 119. Chiesi Recent Developments/Updates
    Table 120. Sumitomo Dainippon Pharma Corporation Information
    Table 121. Sumitomo Dainippon Pharma Description and Business Overview
    Table 122. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Sumitomo Dainippon Pharma Asthma Preventive Product
    Table 124. Sumitomo Dainippon Pharma Recent Developments/Updates
    Table 125. Amgen Corporation Information
    Table 126. Amgen Description and Business Overview
    Table 127. Amgen Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Amgen Asthma Preventive Product
    Table 129. Amgen Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Asthma Preventive Distributors List
    Table 133. Asthma Preventive Customers List
    Table 134. Asthma Preventive Market Trends
    Table 135. Asthma Preventive Market Drivers
    Table 136. Asthma Preventive Market Challenges
    Table 137. Asthma Preventive Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Asthma Preventive
    Figure 2. Global Asthma Preventive Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Asthma Preventive Market Share by Type in 2023 & 2030
    Figure 4. Sodium Cromolyn Product Picture
    Figure 5. Prednisolone Product Picture
    Figure 6. Global Asthma Preventive Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Asthma Preventive Market Share by Application in 2023 & 2030
    Figure 8. Children
    Figure 9. Adult
    Figure 10. Global Asthma Preventive Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Asthma Preventive Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Asthma Preventive Sales (2019-2030) & (K Units)
    Figure 13. Global Asthma Preventive Average Price (USD/Unit) & (2019-2030)
    Figure 14. Asthma Preventive Report Years Considered
    Figure 15. Asthma Preventive Sales Share by Manufacturers in 2023
    Figure 16. Global Asthma Preventive Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Asthma Preventive Players: Market Share by Revenue in 2023
    Figure 18. Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Asthma Preventive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Asthma Preventive Sales Market Share by Country (2019-2030)
    Figure 21. North America Asthma Preventive Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Asthma Preventive Sales Market Share by Country (2019-2030)
    Figure 25. Europe Asthma Preventive Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Asthma Preventive Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Asthma Preventive Revenue Market Share by Region (2019-2030)
    Figure 33. China Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Asthma Preventive Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Asthma Preventive Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Asthma Preventive Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Asthma Preventive Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. U.A.E Asthma Preventive Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Asthma Preventive by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Asthma Preventive by Type (2019-2030)
    Figure 55. Global Asthma Preventive Price (USD/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Asthma Preventive by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Asthma Preventive by Application (2019-2030)
    Figure 58. Global Asthma Preventive Price (USD/Unit) by Application (2019-2030)
    Figure 59. Asthma Preventive Value Chain
    Figure 60. Asthma Preventive Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Respiratory Care Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39Z339
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Albuterol API Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33K8128
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Critical Respiratory Care Ventilators Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38Y8210
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Asthma Preventive Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34J7209
Mon Feb 19 00:00:00 UTC 2024

Add to Cart